Literature DB >> 22614753

What is personalized medicine and what should it replace?

David C Whitcomb1.   

Abstract

Personalized medicine is a new framework for medical care that involves modelling and simulation of a disease on the basis of its underlying mechanisms. This strategy must replace the 20(th) century paradigm of defining disease by pathology or associated signs and symptoms and conducting outcomes research that is based on the presence or absence of the disease syndrome. New technologies, including next-generation sequencing, the 'omics' and powerful computers provide massive amounts of accurate data. However, attempts to understand complex disorders by applying these new technologies within the 20(th) century framework have failed to produce the expected medical advances. To help physicians embrace a paradigm shift, the limitations of the old framework and major advantages of the new framework must be demonstrated. Chronic pancreatitis is an ideal complex disorder to study to consider the pros and cons of the two frameworks, because the pancreas is such a simple organ for disease modelling, and the advantages of personalized medicine are so profound.

Entities:  

Mesh:

Year:  2012        PMID: 22614753      PMCID: PMC3684057          DOI: 10.1038/nrgastro.2012.100

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  38 in total

Review 1.  Hereditary pancreatitis: new insights into acute and chronic pancreatitis.

Authors:  D C Whitcomb
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Identification of disease-specific genes in chronic pancreatitis using DNA array technology.

Authors:  H Friess; J Ding; J Kleeff; Q Liao; P O Berberat; J Hammer; M W Büchler
Journal:  Ann Surg       Date:  2001-12       Impact factor: 12.969

3.  Evidence-based medicine. A new approach to teaching the practice of medicine.

Authors: 
Journal:  JAMA       Date:  1992-11-04       Impact factor: 56.272

Review 4.  Mechanisms of disease: Advances in understanding the mechanisms leading to chronic pancreatitis.

Authors:  David C Whitcomb
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2004-11

Review 5.  Chronic pancreatitis.

Authors:  M L Steer; I Waxman; S Freedman
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

Review 6.  Chronic pancreatitis: diagnosis, classification, and new genetic developments.

Authors:  B Etemad; D C Whitcomb
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

7.  A mathematical model of the pancreatic duct cell generating high bicarbonate concentrations in pancreatic juice.

Authors:  David C Whitcomb; G Bard Ermentrout
Journal:  Pancreas       Date:  2004-08       Impact factor: 3.327

8.  Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis.

Authors:  Véronique D Morinville; Mark E Lowe; Beth D Elinoff; David C Whitcomb
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

9.  Smoking cessation at the clinical onset of chronic pancreatitis and risk of pancreatic calcifications.

Authors:  Giorgio Talamini; Claudio Bassi; Massimo Falconi; Nora Sartori; Bruna Vaona; Paolo Bovo; Luigi Benini; Giorgio Cavallini; Paolo Pederzoli; Italo Vantini
Journal:  Pancreas       Date:  2007-11       Impact factor: 3.327

10.  Comparison of histological features and inflammatory cell reaction in alcoholic, idiopathic and tropical chronic pancreatitis.

Authors:  S V Shrikhande; M E Martignoni; M Shrikhande; A Kappeler; H Ramesh; A Zimmermann; M W Büchler; H Friess
Journal:  Br J Surg       Date:  2003-12       Impact factor: 6.939

View more
  32 in total

1.  Integrating molecular, histopathological, neuroimaging and clinical neuroscience data with NeuroPM-box.

Authors:  Yasser Iturria-Medina; Félix Carbonell; Atousa Assadi; Quadri Adewale; Ahmed F Khan; Tobias R Baumeister; Lazaro Sanchez-Rodriguez
Journal:  Commun Biol       Date:  2021-05-21

Review 2.  Insights into the genetic risk factors for the development of pancreatic disease.

Authors:  Zachary Zator; David C Whitcomb
Journal:  Therap Adv Gastroenterol       Date:  2017-01-05       Impact factor: 4.409

Review 3.  Genetic risk factors for pancreatic disorders.

Authors:  David C Whitcomb
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

4.  Innovation and hard work: The 2015 George E. Palade Medal Award Lecture.

Authors:  David C Whitcomb
Journal:  Pancreatology       Date:  2015-09-16       Impact factor: 3.996

5.  Genetics and treatment options for recurrent acute and chronic pancreatitis.

Authors:  Celeste A Shelton; David C Whitcomb
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

6.  Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition.

Authors:  David C Whitcomb; Luca Frulloni; Pramod Garg; Julia B Greer; Alexander Schneider; Dhiraj Yadav; Tooru Shimosegawa
Journal:  Pancreatology       Date:  2016-02-16       Impact factor: 3.996

7.  Peering Into the "Black Box" of the Complex Chronic Pancreatitis Syndrome.

Authors:  David C Whitcomb
Journal:  Pancreas       Date:  2016-11       Impact factor: 3.327

8.  Biopsy and personalized medicine.

Authors:  Hayet Amalou; Bradford J Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

Review 9.  Genetics of alcoholic and nonalcoholic pancreatitis.

Authors:  David C Whitcomb
Journal:  Curr Opin Gastroenterol       Date:  2012-09       Impact factor: 3.287

Review 10.  Genetics of pancreatitis with a focus on the pancreatic ducts.

Authors:  J Larusch; D C Whitcomb
Journal:  Minerva Gastroenterol Dietol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.